Adjuvant Capital is a venture capital firm that finances promising life science technologies for high-burden public. See sector focus and contact routes.
Adjuvant Capital is a venture capital firm that finances promising life science technologies for high-burden public health challenges. The firm focuses on historically overlooked market segments, leveraging its expertise to achieve both social and financial returns. They invest in innovative technologies to address neglected infectious diseases, maternal and child health, nutrition, and reproductive/sexual health, with a goal of accelerating global availability of impactful medical innovations.
This profile is part of the StartupFundraising firm database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in New York.
Investors like Adjuvant Capital · Full investor directory · Investor access · Company funding database